Henry Schein gets $250 million investment from private equity firm KKR
Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...
Q1 EPS Estimates for Henry Schein Reduced by Analyst
Analysts at Barrington Research cut their Q1 2025 earnings estimates for shares of Henry Schein in a research report issued ...
KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
HME News1d
Henry Schein CEO honored
Henry Schein, Inc., has announced that Stanley M. Bergman, chairman of the board and CEO, has received the National Association of Wholesaler-Distributors (NAW) Dirk Van Dongen Lifetime ...
MassDevice8d
Henry Schein gets a major private equity investment
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...
KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein shares up on strategic investment from KKR, management appointments, share buyback, and preliminary results.
Barrington Research Issues Positive Forecast for Henry Schein (NASDAQ:HSIC) Stock Price
Henry Schein (NASDAQ:HSIC – Free Report) had its price objective hoisted by Barrington Research from $82.00 to $90.00 in a research note published on Thursday,Benzinga reports. They currently have an ...
Yahoo Finance8d
Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance
MELVILLE, N.Y., January 29, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) ("Henry Schein" or the "Company"), the world’s largest provider of health care ...
What Analysts Are Saying About Henry Schein Stock
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Strategic Investment and Growth Potential Drive Buy Rating for Henry Schein Despite Underwhelming Guidance
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Henry Schein announces $250M strategic investment by KKR, board changes
Henry Schein (HSIC) announced a strategic investment by funds affiliated with KKR,(KKR) a global investment firm.In addition to KKR’s current ...